APL Healthcare Limited Pseudoephedrine Export Data — India (DGFT 2022–2026)

Name: APL Healthcare Limited Pseudoephedrine Export Records India — #8 Exporter, 4 Shipments, $93.2K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Pseudoephedrine

India Pharmaceutical Trade Intelligence

$11.9M17 Suppliers13 CountriesHS 30049099

ExportsIndia → NIGERIA39.0%India → UNITED STATES36.7%

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: OHM LABORATORIES

APL Healthcare Limited — Pseudoephedrine Exporter #8 | $93.2K Trade Value | TransData Nexus | TransData Nexus

APL Healthcare Limited — Pseudoephedrine Exporter Profile

Indian Pharmaceutical Exporter · #8 for Pseudoephedrine · $93.2K export value · DGFT Verified

APL Healthcare Limited is the #8 Indian exporter of Pseudoephedrine with $93.2K in export value and 4 verified shipments. APL Healthcare Limited holds a 0.8% market share in Pseudoephedrine exports across 1 countries. The company exports 17 pharmaceutical products worth $27.3M across 11 therapeutic categories.

APL Healthcare Limited — Pseudoephedrine Export Profile: Buyers & Destinations

APL Healthcare Limited Pseudoephedrine export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Pseudoephedrine?

Country	Value	Shipments	Share
NIGERIA	$2.3M	46	33.6%
UNITED STATES	$2.3M	46	33.6%
CANADA	$1.6M	31	22.6%
KENYA	$260.7K	13

Who Are the Top Buyers of Pseudoephedrine from India?

Buyer	Country	Value	Orders
VITA HEALTH PRODUCTS INC	CANADA	$1.4M	29
OHM LABORATORIES INC	UNITED STATES	$1.4M	28
EMBASSY PHARMACEUTICAL AND	NIGERIA	$1.2M	24
OHM LABORATORIES INC.	UNITED STATES	$450.0K	9
EMBASSY PHARMACEUTICAL & CHEMICALS	NIGERIA	$400.0K	8
EMBASSY PHARMACEUTICAL AND CHEMICALS LIMITED	NIGERIA	$350.0K	7
REED-LANE INC	UNITED STATES	$200.0K	4
SUN PHARMA EAST AFRICA LIMITED	KENYA	$172.9K	4
EMBASSY PHARMACEUTICAL AND CHEMICALS LTD	NIGERIA	$100.0K	2
VITA HEALTH PRODUCTS INC.	CANADA	$100.0K	2

India's Pseudoephedrine is purchased by 25 buyers worldwide. The top buyer is VITA HEALTH PRODUCTS INC (CANADA), followed by OHM LABORATORIES INC and EMBASSY PHARMACEUTICAL AND.

How Does APL Healthcare Limited Compare to Nearest Pseudoephedrine Exporters?

Exporters ranked immediately above and below #8 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
6	SUN PHARMACEUTICAL INDUSTRIES LTD	$200.0K	4	1	$50.0K
7	HIGLANCE LABORATORIES PRIVATE LIMITED	$97.3K	3	1	$32.4K
8	APL HEALTHCARE LIMITED ★	$93.2K	4	1	$23.3K
9	IPCA LABORATORIES LIMITED	$87.8K	9	1	$9.8K
10	ALPS LIFE SCIENCES PRIVATE LIMITED	$85.3K	8	1	$10.7K

APL Healthcare Limited ranks #8 among 17 Indian Pseudoephedrine exporters. Average shipment value of $23.3K compared to the market average of $394.9K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LTD and HIGLANCE LABORATORIES PRIVATE LIMITED.

Which Indian Ports Ship Pseudoephedrine Exports?

Port	Shipments	% Share
PATLI ICD	28	17.3%
SAHAR AIR	21	13.0%
SAHAR AIR CARGO ACC (INBOM4)	14	8.6%
HYDERABAD ACC (INHYD4)	13	8.0%
HYDERABAD AIR	9	5.6%
Bombay Air Cargo	9	5.6%
SONEPAT ICD (INBDM6)	8	4.9%
PATLI ICD (INPTL6)	8	4.9%

Geopolitical & Trade Policy Impact on APL Healthcare Limited's Pseudoephedrine Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like APL Healthcare. The Israel-Iran conflict has disrupted Red Sea shipping routes, leading to increased freight costs and extended transit times. These disruptions are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and inventory management. (pharmaceuticalcommerce.com)

Conversely, US-China trade tensions have prompted the United States to seek alternative pharmaceutical suppliers, potentially benefiting Indian exporters. However, the looming threat of US tariffs on pharmaceutical imports adds a layer of uncertainty. In March 2025, Indian pharma exports to the US surged by 74% amid tariff concerns, indicating proactive measures by exporters to mitigate potential impacts. (business-standard.com)

The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on pharmaceuticals, enhancing market access for Indian exporters. This development offers APL Healthcare an opportunity to strengthen its presence in the European market, provided it aligns with EU regulatory standards. (en.wikipedia.org)

APL Healthcare Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. India has made significant strides in this area, with 752 FDA-approved, 2,050 WHO GMP-certified, and 286 EDQM-approved manufacturing sites as of 2024. (business-standard.com) This robust compliance framework enhances the credibility of Indian pharmaceuticals in global markets.

For APL Healthcare, maintaining and enhancing compliance with FDA, WHO, and EU GMP standards is crucial. Adherence to evolving quality requirements not only ensures market access but also builds trust with international partners. Continuous investment in quality assurance and regulatory affairs will be essential to navigate the complex global pharmaceutical landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Pseudoephedrine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: APL Healthcare Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 13+ countries, 25+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Pseudoephedrine

Pseudoephedrine

APL Healthcare Limited — Pseudoephedrine Exporter Profile

APL Healthcare Limited — Pseudoephedrine Export Profile: Buyers & Destinations

Where Does India Export Pseudoephedrine?

Who Are the Top Buyers of Pseudoephedrine from India?

What Is India's Total Pseudoephedrine Export Value and How Much Does APL Healthcare Limited Contribute?

What Is the Average Shipment Value for APL Healthcare Limited's Pseudoephedrine Exports?

How Does APL Healthcare Limited Compare to Other Indian Pseudoephedrine Exporters?

Regulatory Requirements: Exporting Pseudoephedrine to Key Markets

Nigeria — NAFDAC

United States — FDA

How Does APL Healthcare Limited Compare to Nearest Pseudoephedrine Exporters?

Which Indian Ports Ship Pseudoephedrine Exports?

Geopolitical & Trade Policy Impact on APL Healthcare Limited's Pseudoephedrine Exports

APL Healthcare Limited — Regulatory Compliance & Quality Standards

About APL Healthcare Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Pseudoephedrine Export Data from APL Healthcare Limited

Pseudoephedrine Stats

Company Overview

Top Products by APL Healthcare Limited

Related Analysis

Need Detailed Export Data?

Data Source